Episurf Medical will exhibit at the ICRS Heritage Summit, held in Gothenburg, Sweden, on June 29 – July 1

Episurf Medical AB (NASDAQ: EPIS B) will exhibit at the ICRS Heritage Summit in Gothenburg, Sweden (Gothia Towers Hotel) on June 29 – July 1. This international meeting celebrates the 20th   anniversary of the International Cartilage Repair Society (ICRS), a   global society   promoting scientific research and   knowledge exchange   amongst   physicians, scientists and patients focused around   the field of cartilage repair. This summit will review the past, the present and the future of cartilage science. Professor Leif Ryd, Senior Medical Advisor of Episurf Medical, has been invited to talk about Episealer as an alternative to standard cartilage repair treatments.

For the full program, see link: https://cartilage.org/icrs-heritage-summit-gothenburg/
For an overview of the industry conferences attended by Episurf Medical, see link:
www.episurf.com/healthcare-professionals/conferences

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical  

Tel: +46 (0) 709 62 36 69

Email:  pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags:

About Us

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.